Olga Wildfeuer
Internal Medicine · Brooklyn, NYNPI 1184652067
Payments from drug & device makers
Across 1,654 payments — averaging $36.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$7K
- AbbVie$7K
- AstraZeneca$6K
- Gilead$5K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
- Johnson & Johnson$3K
- plus $30K from 54 others
What the payments were for
- Consulting fees$2500%
- Speaking & faculty fees$1,0502%
- Food & beverage$58,89597%
- Education$5811%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$60,775 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 27 | $119,674 |
| CabenuvaCabotegravir/Rilpivirine | 24 | $110,935 |
| OzempicSemaglutide | 110 | $101,339 |
| ZenpepLipase/Protease/Amylase | 28 | $99,481 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 21 | $77,506 |
| FarxigaDapagliflozin Propanediol | 135 | $76,890 |
| ZtlidoLidocaine | 67 | $61,731 |
| RelistorMethylnaltrexone Bromide | 15 | $45,449 |
| DovatoDolutegravir Sodium/Lamivudine | 15 | $41,756 |
| KerendiaFinerenone | 65 | $40,086 |
| ProliaDenosumab | 22 | $35,290 |
| LinzessLinaclotide | 65 | $32,936 |
| TrintellixVortioxetine Hydrobromide | 66 | $30,778 |
| Xigduo XrDapaglifloz Propaned/Metformin | 50 | $27,396 |
| EliquisApixaban | 48 | $27,033 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyCabenuva, Dovato | $7,037 | $152,69139 claims |
| Janssen Products, LPSymtuza | $1,773 | $119,67427 claims |
| GileadBiktarvy, Vemlidy | $4,665 | $104,44540 claims |
| Novo NordiskOzempic | $2,639 | $101,339110 claims |
| Aimmune Therapeutics, Inc.Zenpep | $544 | $99,48128 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $6,176 | $86,499151 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $1,846 | $61,73167 claims |
| AbbVieLinzess, Vraylar | $6,650 | $57,30579 claims |
| PfizerEliquis, Nurtec Odt | $23 | $49,75160 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $3,320 | $45,44915 claims |
| BayerKerendia | $719 | $40,08665 claims |
| AmgenProlia | $1,678 | $35,29022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Brooklyn
- Bruce BergerBrooklyn$3.4M
- Nelly CohenBrooklyn$2.8M
- Jorge SerjeBrooklyn$1.3M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.